Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,119,425 | 1,079,979 | 863,393 | 734,444 | 753,155 |
| Marketable Securities | 52,261 | 46,948 | 189,383 | 174,859 | 170,234 |
| Receivables | 293,948 | 180,340 | 247,486 | 247,043 | 191,001 |
| Inventories | 20,108 | 25,550 | 29,330 | 28,331 | 29,104 |
| Other current assets | 187,539 | 161,357 | 128,319 | 223,739 | 204,963 |
| TOTAL | $1,724,671 | $1,547,196 | $1,503,435 | $1,459,572 | $1,401,008 |
| Non-Current Assets | |||||
| PPE Net | 543,550 | 541,963 | 546,650 | 551,027 | 549,495 |
| Investments And Advances | 49,337 | 52,149 | 74,768 | 127,294 | 141,720 |
| Intangibles | 483,401 | 489,376 | 495,763 | 500,896 | 511,424 |
| Other Non-Current Assets | 295,895 | 286,641 | 283,290 | 306,044 | 289,637 |
| TOTAL | $1,372,183 | $1,370,129 | $1,400,471 | $1,485,261 | $1,492,276 |
| Total Assets | $3,096,854 | $2,917,325 | $2,903,906 | $2,944,833 | $2,893,284 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,631 | 12,617 | 10,047 | 9,041 | 13,700 |
| Accrued Expenses | 250,253 | 219,974 | 210,241 | 245,869 | 242,052 |
| Other current liabilities | 21,202 | 15,436 | 18,025 | 19,745 | 19,785 |
| TOTAL | $316,419 | $267,109 | $257,702 | $307,254 | $293,459 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 201,726 | 211,664 | 209,214 | 268,124 | 261,286 |
| TOTAL | $209,218 | $211,811 | $209,307 | $268,302 | $261,124 |
| Total Liabilities | $525,637 | $478,920 | $467,009 | $575,556 | $554,583 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,613 | 100,349 | 100,595 | 100,659 | 100,969 |
| Common Shares | 100 | 99 | 99 | 99 | 99 |
| Retained earnings | 2,565,670 | 2,443,138 | 2,448,389 | 2,395,575 | 2,351,251 |
| Other shareholders' equity | 5,447 | -4,832 | -11,591 | -26,397 | -12,649 |
| TOTAL | $2,571,217 | $2,438,405 | $2,436,897 | $2,369,277 | $2,338,701 |
| Total Liabilities And Equity | $3,096,854 | $2,917,325 | $2,903,906 | $2,944,833 | $2,893,284 |